Health Technology Assessment of Multiplex Reverse Transcriptase Polymerase Chain Reaction Screening for Translocations at Diagnosis in Acute Myeloid Leukaemia

Hans Erik Johnsen(Herlev Hospital), Karen Dybkær(Aalborg University Hospital), Mette Nyegaard(Statens Serum Institut), Ulla H Davidsen(University of Copenhagen), Olav J. Bergmann(Hospital South West Jutland), Anne Bukh(Aalborg University Hospital), Marianne Hoffmann(Herlev Hospital), Martin Boegsted(Aalborg University Hospital), Tobias Wirenfeldt Klausen(Copenhagen University Hospital)

European Oncology & Haematology

January 1, 2010

10.17925/eoh.2010.04.0.39

Cited by 1

Related Papers

Common variants conferring risk of schizophrenia

|Nature|2009|1.7k

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|396

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

|Blood|2009|390

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

|Leukemia|2012|362